SV LIFE Sciences FUND IV Strategic Partners, L. P., 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), sold 191,468 shares at $27.66 ($5.4M) on 2019-04-01, disclosed to the SEC on 2019-04-02.
Open-market sale of $5.4M KALV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.40 | 969 | $28K | 0.5% |
| 2 | $28.40 | 34,133 | $969K | 18.1% |
| 3 | $28.40 | 34,133 | $969K | 18.1% |
| 4 | $27.66 | 1,458 | $40K | 0.8% |
| 5 | $27.66 | 51,373 | $1.4M | 26.5% |
| 6 | $27.66 | 51,373 |
| $1.4M |
| 26.5% |
| 7 | $28.76 | 253 | $7K | 0.1% |
| 8 | $28.76 | 8,888 | $256K | 4.8% |
| 9 | $28.76 | 8,888 | $256K | 4.8% |
| Total | $28.03 avg | 191,468 | $5.4M | 100% |
| Filing → |
| OCUL | SELL | 2015-06-11 | $16.4M | — | Filing → |
| OPHT | SELL | 2014-06-05 | $55.8M | — | Filing → |
| TRXC | BUY | 2014-04-23 | $3.0M | — | Filing → |